Sumitomo Mitsui Trust Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 303,669 shares of REGN stock, worth $180 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
303,669
Previous 302,616
0.35%
Holding current value
$180 Million
Previous $216 Million
10.65%
% of portfolio
0.14%
Previous 0.15%
Shares
32 transactions
Others Institutions Holding REGN
# of Institutions
1,470Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.57 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.35 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.83 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.36 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $63.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...